Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10032


Purpose:

The purpose of this study is to determine if a reduced intensity (RI) (non-myeloablative) chemoimmunotherapy followed by Allogeneic Stem Cell Transplantation AlloSCT (matched family donors and matched unrelated cord blood donors) will be well tolerated.


Study summary:

This is to test whether a reduced intensity will result in a high degree of mixed or complete donor chimerism and stabilization of autoimmune disease in a select group of patients with medically refractory SLE or SSc.


Criteria:

Inclusion Criteria: - Diffuse Systemic Sclerosis and variants as per ACR criteria - Medically refractory disease - Adequate Organ Function - Pulmonary function - Renal function, Cardiac function defined as: - SGOT (AST) or SGPT (ALT) <5 x upper limit of normal - Diagnosis of SLE - Medically refractory disease Exclusion Criteria: - Karnofsky/Lansky <60%


NCT ID:

NCT00684255


Primary Contact:

Principal Investigator
Mitchell Cairo, MD
Columbia University


Backup Contact:

N/A


Location Contact:

New York, New York 10032
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: February 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.